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A b s t r a c t 
One of the most important assumption of rational choice theory is that individuals are purely self-
interested utility maximizers. However research in economics and other social sciences has found 
that people can also be irrational and their choices can also be taken with some heuristics and biases. 
Laboratory experiments have documented substantial heterogeneity in irrational preferences, but 
little is known about the origins of such irrational financial behavior. Especially in recent studies, it 
is seen that the inheritance estimates of these differences are investigated by using quantitative and 
molecular genetic methods. 
 
The main purpose of this study is to investigate the effects of dopamine and serotonin-related genes 
on financial decisions. For this purpose, genes associated with dopamine and serotonin were 
identified. Some of the studies investigating the effects of these genes on financial decision making 
process have been examined. 
  
 
 
Introduction 
The biological basis of financial decisions and heuristics or 
biases, such as reward dependence, loss aversion, is not yet fully 
understood. However, the anatomy of choice and financial 
decisions has been well-studied.  
 
In particular, studies on decision making are handled together 
with psychology, neurology and genetic sciences. The 
experimental background of these studies consists of personality 
tests in psychology, brain imaging techniques in neurology and 
genes, hormones and neurotransmitters in genetics. 
 
The current studies from neurofinance, neuroeconomics, 
psychology and of course neuroscience discussed about three 
decision-making systems in the human brain, and dopamine and 
serotonin is the principal neurotransmitter that is involved in these 
three systems (Wargo, Baglini and Nelson, 2010): 
1. An unconscious, intuitive and emotional system, 
2. A conscious, rational system or executive function, 
3. A system of habitual behavior that is either 
preprogrammed genetically or developed into habits over time. 
 
Limbic system - the emotional center of the brain – is about some 
behaviors and some biases in financial decisions such as 
reward/approach, loss/avoidance, investment behavior or novelty 
seeking (Knutson & Cooper, 2005; Taylor, 2006). Any problems 
in this system can make you more willing to take risks, greed or 
dependence. 
 
The effects of genes are not expressed directly at the level of 
behavior, but are mediated by their effects on brain regions 
responsible for specific cognitive and emotional processes (Bigos 
and Weinberger, 2010). On the other hand, hormones and 
neurotransmitters can have an effect on behaviors by changing an 
individual´s phenotype (Soares et al., 2010), moreover these 
behaviors can also be influenced by genetic and epigenetic 
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differences (Liu et al., 1997; Meaney, 2001). Empirical findings 
from genoeconomics and neuroeconomics (Benjamin et al., 2007; 
Beauchamp et al., 2011; Navarro, 2009) suggest that this holds 
true for economic behavior as well. Some researchers have 
identified a significant degree of genetic influence on variables 
such as change in decisions to invest in equity securities (Barnea 
et al. 2010), income (Taubman 1976), risk preferences (Zhong, 
Chew et al., 2009), cooperativeness in trust games (Cesarini et al., 
2008), bargaining behavior (Wallace et al., 2007), and 
preferences for giving and taking risks (Cesarini et al., 2009).  
 
Studies in healthy people and diagnosed people with mood 
disorders or psychiatric disorders have shown that: risk-taking or 
risk-avoiding behavior is associated with genetic variations in 
dopaminergic and serotonergic pathways. In addition, the 
relationship between cognitive and emotional biases and genetic 
variations in financial decisions has been discussed and proved in 
other studies. Genes such as COMT, SLC6A4, BDNF and 
Dopamine Receptor Genes are frequently used in such studies. 
Investigation of the fundamentals of financial decisions using 
molecular genetic methods has been studied not only with 
dopamine receptor genes but also with many different genes and 
polymorphisms. One of the genes discussed in such studies is the 
MAOA gene. 
 
1. Dopamine, Serotonin and Some Genes 
Dopamine and serotonin are necessary for normal nervous system 
function, and changes in the levels of these neurotransmitters 
contribute to some psychological disorders. Both dopamine and 
serotonin interact with other neuromodulators to influence choice 
(Doya, 2008).  
 
Dopamine and serotonin, which are chemical messengers that 
transmit signals between nerve cells (neurotransmitters), are 
frequently used in such studies, and U.S. National Library of 
Medicine has identified 27 gene that associated with dopamine 
(CHRNA4, COMT, DBH, DDC, DPYS, DRD2, DRD3, DRD4, 
DRD5, EPB41L1, GBA, GCH1, GNAL, HTR1B, MAOA, 
OPRM1, PARK7, PRKN, RGS9, SLC18A2, SLC6A3, SNCA, 
SPR, TAAR1, TH, TOR1A, UPB1) and 14 gene that associated 
with serotonin CC2D1A, DDC, FEV, GCH1, HTR1A, HTR1B, 
HTR2A, MAOA, SLC18A2, SLC6A4, SNORD115-1, SPR, 
TAAR1, TPH2). Given that these genes are involved in both the 
dopaminergic serotonergic pathways, two pathways that play 
critical roles in emotional processing, this gene may contribute to 
a series of processes involved in affective processing (Gao, Liu et 
al. 2017). The genes that appear to be associated with both 
serotonin and dopamine are: DDC gene, GCH1 gene, HTR1B 
gene, MAOA gene, SLC18A2 gene, SPR gene and TARR1 gene.  
As seen as, the MAOA gene is one of the genes associated with 
both dopamine and serotonin.  
 
 
Johnston (1968) defined two subtypes of MAO based on the 
observation that one form (A) but not the other (B) was sensitive 
to the irreversible inhibitor, clorgyline. The U.S. National Library 
of Medicine describes the MAOA gene and its role in the 
breakdown of neurotransmitters such as serotonin and dopamine: 
“The MAOA gene provides instructions for making an enzyme 
called monoamine oxidase A. Specifically, monoamine oxidase 
A is involved in the breakdown of the neurotransmitters 
serotonin, epinephrine, norepinephrine, and dopamine. Signals 
transmitted by serotonin regulate mood, emotion, sleep, and 
appetite. Epinephrine and norepinephrine control the body's 
response to stress. Dopamine transmits signals within the brain to 
produce smooth physical movements.” 
 
 
Monoamine oxidase A (MAOA) gene located in Xp11.3 spanning 
15 exons containing 527 amino acids and codes for MAOA 
protein. The function of MAOA enzyme is to degrade 
monoaminergic neurotransmitters (adrenaline, noradrenaline, 
serotonin and dopamine) in the brain. These neurotransmitters 
play an important role in arousal, emotions, mood and even 
affecting impulse control (Ramakrishnan and Akram Husain, 
2017). There are also studies linking the MAOA gene with some 
psychological disorders like schizophrenia, bipolar disorder and 
major depressive disorder. Different variants of it regulate 
transcription, metabolism, and signal transfer between neurons, 
all of which have an effect on social interactions (Craig, 2007; 
Spitzer et al., 2007). The less transcriptionally efficient alleles are 
called MAOA-L, and the more efficient are called MAOA-H 
(Sabol et al., 1998). MAOA-L has been found to be associated 
with various kinds of antisocial behavior, including violence and 
aggression, both in the field (Caspi et al., 2002) and in the lab 
(Gallardo-Pujol et al., forthcoming). McDermott et al. (2009) 
show an association between MAOA-L in males and behavioral 
aggression following provocation. 
 
 
Studies revealing the association of variations in the MAOA gene 
with psychological disorders such as aggression and mood 
disorder have led to the investigation of the relationship between 
excessive risk-taking behavior and excessive self-esteem bias 
with the MAOA gene in financial decisions. Previous literature 
suggests may be individual variability in genetic alleles (Raine, 
2008), and this variability can cause some irrational financial 
decisions, such that individuals with a low activity form of the 
gene that encodes monoamine oxidase A (MAOA-L) will be 
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more likely to react with aggression to challenge, and these 
aggressive behaviors can cause people to behave in extreme risk.  
The MAOA gene, which is thought to have a close relationship 
with aggression behavior in studies about neurobiological basis 
of taking economic risk, is generally considered together with 
gambling addiction in studies where risk taking behavior is 
examined in financial decisions. 
 
 
Ibanez et al. (2000) studied 68 pathological gambling addicts and 
68 control groups and investigated whether there is a relationship 
between MAOA and MAOB genes and pathological gambling 
disease. According to results, there were no significant 
differences between pathological gamblers and healthy 
volunteers in overall allele distribution at the MAOA gene 
polymorphism, but there was a significant association between 
allele distribution and the subgroup of severe male gamblers 
compared to the males in the group of healthy volunteers.  
 
 
Pérez de Castro et al. (2002) studied the relationship between 
pathological gambling dependence and MAOA (MAOA-uVNTR 
polymorphism) in the serotonergic system. At the end of the 
study, the relationship between pathological gambling addiction 
and serotonergic system was emphasized. In the experiment, the 
allelic frequency of the 3-copy allele in MAOA-uVNTR 
polymorphism was found to be higher in the experimental group 
which was gambling dependent and lower in the control group. 
Zhong, Israel et al. (2009) examined the effect of the MAOA gene 
on gambling and insurance behaviors. The fact that people exhibit 
high risk taking behaviors while playing games of chance, but 
insuring other areas of their lives cannot be explained rationality. 
They found that subjects with the high activity (4-repeat) allele 
are characterized by a preference for the longshot lottery and also 
less insurance purchasing than subjects with the low activity (3-
repeat) allele. 
 
 
Frydman, Camerer et al. (2011) combine neuroeconomics and 
behavioral genetic methods to investigate the effect of 
monoamine oxidase-A (MAOA) on risk attitudes. As a result of 
the study, in accordance with the previous literature, they 
concluded that the carriers of MAOA-L polymorphism are more 
likely to take financial risks and can make better financial 
decisions at risk. 
 
 
When looking at the triad of financial decision making, 
personality and genetics, it should be noted that they are all 
closely related. In addition, recent studies have added another 
variable to this trio: Neurology. There are many studies linking 
MAOA uVNTR with brain functions that is realized during 
cognitive, emotional arousal and personality tests (Fan, Fossella 
vd, 2003; Meyer-Linderberg, Buckholtz vd., 2006; Buckholtz, 
Callicott vd. 2008; Cloninger, 1986). Additionally, some brain 
imaging studies have shown an activation of similar brain areas 
in aggression and cooperation (Nelson & Trainor, 2007; Decety 
et al., 2004). Moreover, brain functions during cognition, 
emotional arousal, personality test-takings, and working memory 
activation as well as the function and anatomy of specific brain 
regions in the limbic system were affected by the MAOA VNTR 
(Mertins, Schote and Meyer, 2013). 
 
 
Another common gene identified for dopamine and serotonin is 
the DDC gene. The DDC gene provides instructions for making 
the aromatic l-amino acid decarboxylase (AADC) enzyme, which 
is important in the brain and nervous system, and this enzyme 
takes part in the pathway that produces dopamine and serotonin.  
Based on the results of studies showing that the DDC gene is 
associated with some psychological disorders, such as anxiety 
(Costas et al., 2010) and bipolar disorder (Børglum et al., 2003), 
it can be said that genetic variations in the DDC gene can be a 
candidate gene for decision making genetic studies.  
 
 
Gao, Liu et al. (2017) demonstrated that the genetic variations of 
the DDC gene, gene contributed to individual differences in the 
susceptibility to framing. The framing effect in behavioral finance 
refers the tendency to be risk-averse when options are presented 
positively but be risk-seeking when the same options are 
presented negatively during decision-making.  
 
 
The GCH1 gene provides instructions for making an enzyme 
called GTP cyclohydrolase 1. This enzyme is involved in the 
production of a molecule called tetrahydrobiopterin (BH4). 
Tetrahydrobiopterin is involved in reactions that produce 
chemicals called dopamine and serotonin neurotransmitters, 
which transmit signals between nerve cells in the brain. 
 
 
The GCH1 gene is generally known as a gene with pain 
sensitivity and potential to develop chronic pain (George, Wu et 
al.). However, mutations in the GCH1 gene have been identified 
in the following 3 clinically different neurometabolic disorders: 
dystonia, hyperphenylalaninemia and compound heterozygote 
mutations of the GCH1 gene with a neurologic disorder 
intermediate in severity between the above disorders (Hahn, Trant 
and Brownstein, 2001). However, in the literature, there is no 
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study showing the direct relationship of this gene to decision 
making or financial decision making. 
 
 
The HTR1B encoded by this intronless gene is a G-protein 
coupled receptor for serotonin (5-hydroxytryptamine).  
 
 
Benko et al. (2010) examined the association between the C (-
1019) G functional polymorphism, regulating the HTR1A gene 
expression, and impulsiveness. The C (-1019) G genotype groups, 
showed significant differences: GG type subjects showed 
significantly higher motor and cognitive impulsiveness. 
According to these findings suggest that the receptor gene, 
HTR1A, expression was involved in a continuum phenotype of 
impulsiveness. However, in the literature, there is no study 
examining the relationship between HTR1B and decision-making 
or financial decisions.  
 
 
According to the U.S. National Library of Medicine, SLC18A2 
gene encodes a transmembrane protein that functions as an ATP-
dependent transporter of monoamines, such as dopamine, 
norepinephrine, serotonin, and histamine. Polymorphisms in this 
gene may be associated with schizophrenia, bipolar disorder, 
Parkinsonism, and other neurological/psychiatric ailments. 
However, there is no evidence that the SLC18A2 gene directly 
affects financial behaviors or financial decisions. 
 
 
According to the U.S. National Library of Medicine, the SPR 
gene provides instructions for making the sepiapterin reductase 
enzyme. The sepiapterin reductase enzyme converts a molecule 
called 6-pyruvoyl-tetrahydropterin to tetrahydrobiopterin. 
Tetrahydrobiopterin helps process several building blocks of 
proteins (amino acids), and is involved in the production of 
chemicals called neurotransmitters, which transmit signals 
between nerve cells in the brain. Specifically, tetrahydrobiopterin 
is involved in the production of two neurotransmitters called 
dopamine and serotonin. Although it was associated with 
dopamine and serotonin, no direct correlation was found between 
the SPR gene and decision-making or financial behavior. Like the 
SPR gene, the TARR1 gene has been identified by the U.S. 
National Library of Medical. According to this, the protein 
encoded by this gene is a G-protein coupled receptor activated by 
trace amines. The encoded protein responds little or not at all to 
dopamine, serotonin, epinephrine, or histamine, but responds well 
to beta-phenylethylamine, p-tyramine, octopamine, and 
tryptamine. While primarily functioning in neurologic systems, 
there is evidence that this gene is involved in blood cell and 
immunologic functions as well. There is no evidence that the 
TARR1 gene affects behaviors or financial decisions. 
 
 
Discussion 
When the genes associated with dopamine and serotonin are 
examined, it is seen that some of the genes have proven to be 
related to decision making. In particular, the findings suggest that 
the MAOA gene plays a role in financial behavior and financial 
decision making. Studies examining the effect of the MAOA gene 
on risk-taking behavior in financial decisions are often addressed 
in conjunction with gambling addiction.  
 
 
In addition to genes commonly used in the field of 
genoeconomics, such as COMT, BDNF, SLC6A4, studies on the 
effect of variations in the MAOA gene on the financial decision 
process are important for genoeconomics and neuroeconomics. 
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